These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33675830)

  • 1. ARID1A knockdown in human endothelial cells directly induces angiogenesis by regulating angiopoietin-2 secretion and endothelial cell activity.
    Yoodee S; Peerapen P; Plumworasawat S; Thongboonkerd V
    Int J Biol Macromol; 2021 Jun; 180():1-13. PubMed ID: 33675830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arid1a regulates response to anti-angiogenic therapy in advanced hepatocellular carcinoma.
    Hu C; Li W; Tian F; Jiang K; Liu X; Cen J; He Q; Qiu Z; Kienast Y; Wang Z; Zhang H; Ji Y; Hu J; Hui L
    J Hepatol; 2018 Mar; 68(3):465-475. PubMed ID: 29113912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knock-down of Pdcd4 stimulates angiogenesis via up-regulation of angiopoietin-2.
    Krug S; Huth J; Göke F; Buchholz M; Gress TM; Göke R; Lankat-Buttgereit B
    Biochim Biophys Acta; 2012 Apr; 1823(4):789-99. PubMed ID: 22289349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenesis by lentivirus-mediated small interfering RNA silencing of angiopoietin-2 gene in pancreatic carcinoma.
    Zhou J; Zhang ZX; Zhao H; Zhu DM; Zhang Y; Li DC
    Technol Cancer Res Treat; 2011 Aug; 10(4):361-9. PubMed ID: 21728393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA PVT1 promotes the angiogenesis of vascular endothelial cell by targeting miR‑26b to activate CTGF/ANGPT2.
    Zheng J; Hu L; Cheng J; Xu J; Zhong Z; Yang Y; Yuan Z
    Int J Mol Med; 2018 Jul; 42(1):489-496. PubMed ID: 29620147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models.
    Leow CC; Coffman K; Inigo I; Breen S; Czapiga M; Soukharev S; Gingles N; Peterson N; Fazenbaker C; Woods R; Jallal B; Ricketts SA; Lavallee T; Coats S; Chang Y
    Int J Oncol; 2012 May; 40(5):1321-30. PubMed ID: 22327175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of biological function on ovarian clear cell carcinoma ES2 cell line with ARID1A gene expression down-regulating in vitro].
    Lyu CS; Zhang YL; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):209-15. PubMed ID: 27030501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiopoietin-2 inhibition using siRNA or the peptide antagonist L1-10 results in antitumor activity in human neuroblastoma.
    D'Souza SS; Scherzinger-Laude K; Simon M; Salimath BP; Rössler J
    J Cancer Res Clin Oncol; 2012 Dec; 138(12):2017-26. PubMed ID: 22777681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early growth response-1 regulates angiopoietin-1-induced endothelial cell proliferation, migration, and differentiation.
    Abdel-Malak NA; Mofarrahi M; Mayaki D; Khachigian LM; Hussain SN
    Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):209-16. PubMed ID: 19112164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-35 Inhibits Angiogenesis through VEGF/Ang2/Tie2 Pathway in Rheumatoid Arthritis.
    Jiang S; Li Y; Lin T; Yuan L; Li Y; Wu S; Xia L; Shen H; Lu J
    Cell Physiol Biochem; 2016; 40(5):1105-1116. PubMed ID: 27960151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide (LPS)-mediated angiopoietin-2-dependent autocrine angiogenesis is regulated by NADPH oxidase 2 (Nox2) in human pulmonary microvascular endothelial cells.
    Menden H; Welak S; Cossette S; Ramchandran R; Sampath V
    J Biol Chem; 2015 Feb; 290(9):5449-61. PubMed ID: 25568324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of ARID1A-interacting proteins in renal tubular cells and their molecular regulation of angiogenesis.
    Yoodee S; Peerapen P; Plumworasawat S; Malaitad T; Thongboonkerd V
    J Transl Med; 2023 Nov; 21(1):862. PubMed ID: 38017409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopoietin-2 TIEs up macrophages in tumor angiogenesis.
    De Palma M; Naldini L
    Clin Cancer Res; 2011 Aug; 17(16):5226-32. PubMed ID: 21576085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiopoietin-2/Tie2 signaling involved in TNF-α induced peritoneal angiogenesis.
    Yuan J; Fang W; Lin A; Ni Z; Qian J
    Int J Artif Organs; 2012 Sep; 35(9):655-62. PubMed ID: 23065888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-370 inhibits the angiogenic activity of endothelial cells by targeting smoothened (SMO) and bone morphogenetic protein (BMP)-2.
    Gu Y; Becker V; Zhao Y; Menger MD; Laschke MW
    FASEB J; 2019 Jun; 33(6):7213-7224. PubMed ID: 30865837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laminar shear inhibits tubule formation and migration of endothelial cells by an angiopoietin-2 dependent mechanism.
    Tressel SL; Huang RP; Tomsen N; Jo H
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2150-6. PubMed ID: 17673702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMYD1, an SRF-Interacting Partner, Is Involved in Angiogenesis.
    Ye X; Qian Y; Wang Q; Yuan W; Mo X; Li Y; Jiang Z; Xu W; Deng Y; Wan Y; Fan X; Wu X; Wang Y
    PLoS One; 2016; 11(1):e0146468. PubMed ID: 26799706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
    Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
    Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Int6/eIF3e silenced HIF2α stabilization enhances migration and tube formation of HUVECs via IL-6 and IL-8 signaling.
    Endler A; Chen L; Li Q; Uchida K; Hashimoto T; Lu L; Xu GT; Shibasaki F
    Cytokine; 2013 Apr; 62(1):115-22. PubMed ID: 23478175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapy.
    Shlamkovich T; Aharon L; Barton WA; Papo N
    Oncotarget; 2017 May; 8(20):33571-33585. PubMed ID: 28422724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.